Drug Pipeline

Lorazepam Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
5
Active Studies
1
Recruiting
1
Phase 3
4
Top Sponsors
Active Studies by Phase
Phase 4
1
Phase 2/3
1
Phase 2
2
Early Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT07428681 Lorazepam for Delirium Prevention in Critically Ill Patients With High Anttila-Index Delirium Confusional State Not Yet Recruiting
Phase 2/3
NCT03743649 Haloperidol and Lorazepam in Controlling Symptoms of Persistent Agitated Delirium in… Delirium Active, Not Recruiting
Phase 2
NCT01949662 Haloperidol and Lorazepam for Delirium in Patients With Advanced Cancer Advanced Cancers Active, Not Recruiting
NCT05662228 Therapies for Down Syndrome Regression Disorder Down Syndrome Active, Not Recruiting
Early Phase 1
NCT07560878 Synaptic Mechanisms of Continuous Theta Burst Stimulation in Depression Major Depression Recruiting
Sponsors Running Lorazepam Trials
M.D. Anderson Cancer Center (2) University of Colorado, Denver (1) University Hospital, Basel, Switzerland (1) Mclean Hospital (1)
Disease Areas
Depression (1)
Get alerts when Lorazepam trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free